M11.251
Other chondrocalcinosis, right hip
Clinical Classification Guidelines
Medical Intelligence & Overview
Chondrocalcinosis of the right hip, classified under ICD-10 code M11.251, is a condition characterized by the deposition of calcium crystals within the cartilage of the hip joint. It often leads to joint pain, stiffness, and swelling, affecting mobility and quality of life. This condition is a specific form of calcium pyrophosphate deposition disease (CPPD), which primarily impacts older adults and those with other joint-related issues. Recognizing and understanding this condition can help in managing symptoms and maintaining joint health.
Causes & Symptoms
Clinical Causes: Aging: The risk of developing chondrocalcinosis increases with age due to changes in cartilage and calcium metabolism. Genetic predisposition: A family history of CPPD or related joint conditions can increase susceptibility. Metabolic disorders: Conditions such as hyperparathyroidism, hemochromatosis, hypophosphatemia, and gout are linked to increased calcium crystal deposition. Joint trauma: Previous injuries or surgeries to the hip may contribute to the development of chondrocalcinosis. Cartilage degeneration: Weakened or deteriorated cartilage provides a site for calcium crystal accumulation.
Key Symptoms: Joint pain, especially during movement or after periods of rest Stiffness in the right hip, making movement difficult Swelling around the affected joint Reduced range of motion in the right hip Tenderness upon palpation of the joint Occasional warmth or redness in the joint area Possible intermittent flare-ups where symptoms worsen temporarily
Diagnostic & Treatment
Diagnosis Path: Physical examination to assess joint tenderness, swelling, and range of motion Imaging techniques such as X-rays, which can reveal calcification deposits within the cartilage Joint aspiration to obtain synovial fluid analysis, identifying calcium pyrophosphate crystals under microscopy Blood tests to evaluate for underlying metabolic or systemic conditions that may contribute to calcium crystal formation
Treatment Protocols: Pain management with nonsteroidal anti-inflammatory drugs (NSAIDs) to reduce inflammation and discomfort Corticosteroid injections into the affected joint for severe flare-ups Physical therapy to improve joint strength and flexibility Lifestyle modifications, including weight management and activity adjustments to lessen joint stress Addressing underlying metabolic disorders through appropriate medical interventions Use of calcium and vitamin D supplements is generally not recommended unless specifically prescribed, as it may influence calcium crystal deposition In some cases, surgical procedures like joint replacement may be considered if joint damage is extensive
Clinical Advice & FAQs
Billing Guidance
Is M11.251 a billable ICD-10 code?
Yes, M11.251 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M11.251?
Clinical documentation must specify the nature of Other chondrocalcinosis, right hip and any associated comorbidities for accurate reporting.
Cite this Clinical Reference